Sumo, Zerodol P and Ace Proxyvan are among many drugs along with Corex and Phensedyl, which will go off the shelf from many chemist shops after the government move to ban about 344 fixed dose combination drugs.
The 344 banned drugs include the fixed dose combination of Chlopheniramine Maleate and Codeine syrup sold under the popular cough syrup brand Corex. Following the government ban, pharmaceutical major Pfizer has discontinued manufacture and sale of Corex with immediate effect.
According to Nomura, the government move is clearly an incremental negative for the companies affected. It however says that if companies can launch new products quickly, they may still be able to retain a large portion of sales.
Here is the list of companies and their products that could be affected
1. Abbott: Cough Syrup Phensedyl, Tossex and triple combination diabetes drug Tribet
2. Pfizer: Cough Syrup Corex
3. Macleods: Panderum Plus
4. Mankind: The impact is spread across multiple products
5. Alkem: Sumo (Nimesulide + Paracetamol) and Taxim AZ (Azithromycin + Cefixime)
6. Sun Pharma: The most impacted is triple anti diabetes combination drug Gemer P (Meltformin + pioglitazone + glimeperide)
7. Ipca: Zerodol P (Paracetamol + Aceclofenac)
8. Glenmark: Most of the impact is on account of Ascoril range of cough syrups
9. Wockhardt: Zedex cough syrups, Ace Proxyvan impacted
10. Lupin: Triple combination diabetes drug Gluconorm most impacted
11. Cipla: Triple combination diabetes drug Triexer most impacted
12. Procter and Gamble (P&G): Vicks Action 500 Extra